Lactate Dehydrogenase/Albumin to Urea Ratio: A Novel Prognostic Indicator for Adverse Outcomes in Patients With Severe Fever With Thrombocytopenia Syndrome
Journal of Medical Virology · 2025
DOI: 10.1002/jmv.70428 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Medical Virology, 2025. Verfasst von Ruihua Zhang und 10 weiteren Autor:innen. Beteiligte Einrichtung: National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing,…. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Urea, L-Lactate Dehydrogenase, Serum Albumin. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: The study was supported by the National Key R&D Program of China (Grant No. 2022YFF1203201), Beijing Research Center for Respiratory Infectious Diseases Projec….
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS) is an emerging infectious disease with significant mortality risks. This study evaluated the predictive value of the lactate dehydrogenase/albumin to urea ratio (LAU) for lethal outcomes in SFTS patients. Clinical data from 348 patients (295 survivors, 53 non‐survivors) admitted to Yantai Infectious Disease Hospital (2022‐2023) were analyzed. Multivariate analysis identified older age, SFTS‐associated encephalopathy, SFTSV RNA, decreased albumin and serum calcium, increased lactate dehydrogenase, and elevated LAU as independent mortality risk factors. LAU demonstrated strong predictive accuracy (AUC: 0.79; 95% CI: 0.72‐0.85; sensitivity 69%, specificity 75%), with an optimal cutoff of 144.685 U·mmol/g·L. Survival analysis linked high LAU to poor prognosis, and longitudinal trends showed decreasing LAU with recovery in survivors but rising levels in non‐survivors. These findings highlight LAU as a novel, practical biomarker for early risk stratification and prognosis improvement in SFTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- National Key Laboratory of Intelligent Tracking and Forecasting for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Department of Infectious Disease, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Beijing Research Center for Respiratory Infectious Diseases, Beijing, China.
- Beijing Key Laboratory of Emerging Infectious Diseases, Institute of Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
- Beijing Institute of Infectious Diseases, Beijing, China.
- National Center for Infectious Diseases, Beijing Ditan Hospital, Capital Medical University, Beijing, China.
ORCID-Profile: Hongxiao Wu, Wei Zhang, Zhihai Chen
Förderung
- The study was supported by the National Key R&D Program of China (Grant No. 2022YFF1203201), Beijing Research Center for Respiratory Infectious Diseases Projec…
Zitieren
APA
Zhang, R., Mu, Y., Zhang, M., Wu, H., Xu, Y., Zhao, C., Liu, Z., Lin, L., Zhang, W., Kong, Y., & Chen, Z. (2025). Lactate Dehydrogenase/Albumin to Urea Ratio: A Novel Prognostic Indicator for Adverse Outcomes in Patients With Severe Fever With Thrombocytopenia Syndrome. Journal of Medical Virology. https://doi.org/10.1002/jmv.70428
Vancouver
Zhang R, Mu Y, Zhang M, Wu H, Xu Y, Zhao C, et al. Lactate Dehydrogenase/Albumin to Urea Ratio: A Novel Prognostic Indicator for Adverse Outcomes in Patients With Severe Fever With Thrombocytopenia Syndrome. Journal of Medical Virology. 2025. doi:10.1002/jmv.70428
BibTeX
@article{Zhang2025,
author = {Zhang, Ruihua and Mu, Yameng and Zhang, Mengyuan and Wu, Hongxiao and Xu, Yanli and Zhao, Chenxi and Liu, Zishuai and Lin, Ling and Zhang, Wei and Kong, Yaxian and Chen, Zhihai},
title = {Lactate Dehydrogenase/Albumin to Urea Ratio: A Novel Prognostic Indicator for Adverse Outcomes in Patients With Severe Fever With Thrombocytopenia Syndrome},
journal = {Journal of Medical Virology},
year = {2025},
doi = {10.1002/jmv.70428}
}
EUVIMED